348 related articles for article (PubMed ID: 33827675)
21. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
[TBL] [Abstract][Full Text] [Related]
22. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
[TBL] [Abstract][Full Text] [Related]
23. A biomarker study in long-lasting amnestic mild cognitive impairment.
Cerami C; Dodich A; Iannaccone S; Magnani G; Santangelo R; Presotto L; Marcone A; Gianolli L; Cappa SF; Perani D
Alzheimers Res Ther; 2018 Apr; 10(1):42. PubMed ID: 29695292
[TBL] [Abstract][Full Text] [Related]
24. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
26. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
[TBL] [Abstract][Full Text] [Related]
27. Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia.
Frings L; Spehl TS; Weber WA; Hüll M; Meyer PT
J Nucl Med; 2013 Nov; 54(11):1909-14. PubMed ID: 24101684
[TBL] [Abstract][Full Text] [Related]
28. Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia.
Giacomucci G; Moschini V; Piazzesi D; Padiglioni S; Caruso C; Nuti C; Munarin A; Mazzeo S; Galdo G; Polito C; Emiliani F; Frigerio D; Morinelli C; Bagnoli S; Ingannato A; Nacmias B; Sorbi S; Berti V; Bessi V
Cortex; 2024 Mar; 172():125-140. PubMed ID: 38301390
[TBL] [Abstract][Full Text] [Related]
29. Associations Between Levels of Peripheral NCAPH2 Promoter Methylation and Different Stages of Alzheimer's Disease: A Cross-Sectional Study.
Hao SW; Li TR; Han C; Han Y; Cai YN
J Alzheimers Dis; 2023; 92(3):899-909. PubMed ID: 36806511
[TBL] [Abstract][Full Text] [Related]
30. Unawareness of memory deficit in amnestic MCI: FDG-PET findings.
Nobili F; Mazzei D; Dessi B; Morbelli S; Brugnolo A; Barbieri P; Girtler N; Sambuceti G; Rodriguez G; Pagani M
J Alzheimers Dis; 2010; 22(3):993-1003. PubMed ID: 20858977
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
32. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
[TBL] [Abstract][Full Text] [Related]
34. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint.
Thomas KR; Weigand AJ; Edwards LC; Edmonds EC; Bangen KJ; Ortiz G; Walker KS; Bondi MW;
Alzheimers Res Ther; 2022 Aug; 14(1):114. PubMed ID: 35996158
[TBL] [Abstract][Full Text] [Related]
35. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
[TBL] [Abstract][Full Text] [Related]
36. Arterial spin labeling versus
Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
[TBL] [Abstract][Full Text] [Related]
37. Biomarker-based stability in limbic-predominant amnestic mild cognitive impairment.
Tondo G; Carli G; Santangelo R; Mattoli MV; Presotto L; Filippi M; Magnani G; Iannaccone S; Cerami C; Perani D;
Eur J Neurol; 2021 Apr; 28(4):1123-1133. PubMed ID: 33185922
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
[TBL] [Abstract][Full Text] [Related]
39. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
40. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY
Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
